IRIS
UBERTI FOPPA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.055
NA - Nord America 1.768
EU - Europa 1.640
SA - Sud America 912
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.685
SG - Singapore 1.181
CN - Cina 951
BR - Brasile 759
SE - Svezia 593
HK - Hong Kong 490
IT - Italia 267
VN - Vietnam 214
RU - Federazione Russa 191
RO - Romania 168
DE - Germania 115
AR - Argentina 66
FI - Finlandia 60
NL - Olanda 52
GB - Regno Unito 50
IN - India 50
CA - Canada 48
BD - Bangladesh 39
EC - Ecuador 29
IE - Irlanda 28
MX - Messico 26
ID - Indonesia 23
PL - Polonia 22
AT - Austria 21
JP - Giappone 19
CO - Colombia 17
FR - Francia 17
ES - Italia 16
UA - Ucraina 16
TR - Turchia 15
ZA - Sudafrica 14
IQ - Iraq 13
VE - Venezuela 12
LT - Lituania 11
PY - Paraguay 11
CL - Cile 10
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 6
PH - Filippine 6
SA - Arabia Saudita 6
KE - Kenya 5
MA - Marocco 5
MY - Malesia 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
IL - Israele 4
TN - Tunisia 4
DZ - Algeria 3
HR - Croazia 3
NP - Nepal 3
PE - Perù 3
SV - El Salvador 3
UY - Uruguay 3
BO - Bolivia 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
PS - Palestinian Territory 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.412
Salva come PNG Salva come JPEG
Città #
Singapore 581
Hong Kong 489
Dallas 340
Shanghai 217
Hefei 207
Lawrence 190
Princeton 190
Ashburn 170
Beijing 126
Milan 101
New York 93
Ho Chi Minh City 80
Moscow 80
Los Angeles 74
São Paulo 67
Helsinki 48
Hanoi 39
Boardman 30
Nuremberg 29
Dublin 28
Guangzhou 26
Munich 25
Rio de Janeiro 25
Rome 25
Pune 21
Santa Clara 19
Seattle 19
Tokyo 19
Warsaw 19
Denver 16
Curitiba 15
London 15
Montreal 15
Dronten 14
Haiphong 14
Toronto 14
Brooklyn 13
Stockholm 13
Shenzhen 12
Atlanta 11
Belo Horizonte 11
Chicago 11
Da Nang 11
Johannesburg 11
Orem 11
Poplar 11
Boston 10
Guayaquil 10
Hangzhou 10
Turku 10
Brasília 9
Chennai 9
Contagem 9
Goiânia 9
Phoenix 9
Tashkent 9
Washington 9
Buenos Aires 8
Cesano Boscone 8
Dhaka 8
Mexico City 8
Porto Alegre 8
The Dalles 8
Campinas 7
Quito 7
Reston 7
Salvador 7
Sorocaba 7
Vienna 7
Ankara 6
Columbus 6
San Francisco 6
Amsterdam 5
Biên Hòa 5
Can Tho 5
Caracas 5
Falkenstein 5
Houston 5
Indaiatuba 5
Kassel 5
Manchester 5
Ribeirão Preto 5
Riyadh 5
Vittoria 5
Vitória da Conquista 5
Wuxi 5
Aracaju 4
Bogotá 4
Bình Dương 4
Caruaru 4
Caxias do Sul 4
Changsha 4
Council Bluffs 4
Cuenca 4
Erbil 4
Florence 4
Ha Long 4
Hamilton 4
Hải Dương 4
Ipatinga 4
Totale 3.932
Salva come PNG Salva come JPEG
Nome #
Monkeypox in a patient with undifferentiated connective tissue disease 214
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 130
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 101
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 93
Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients with Advanced Liver Disease during Anti-HCV Treatment with Direct-Acting Antiviral Regimens Including Ribavirin 78
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 76
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy 74
HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts 70
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study) 70
Condom use with steady partners among heterosexual people living with HIV in Europe: Testing the information-motivation-behavioral skills model 70
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 67
Association between the presence of CCR5-specific antibodies and long term non progression 67
A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients 67
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 65
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 62
Characterization of GBV-C infection in HIV-1 infected patients 59
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS). 59
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 58
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis 58
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 57
ABC of AIDS: Treatment of infections and antiviral agents 55
Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases 53
A RETROSPECTIVE STUDY OF PRIMARY AND MAINTENANCE THERAPY OF TOXOPLASMIC ENCEPHALITIS WITH ORAL CLINDAMYCIN AND PYRIMETHAMINE 53
Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients 51
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment 51
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 51
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 50
A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study 50
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? 49
Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. 49
Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption 48
Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman 48
Carri, S; Fantini, R; Ferrara, G; Luppi F; Marchionni A; Pardi Roberto; Richeldi L; Roversi P; Uberti Foppa Caterina Capitolo 18 - Influenza in Medicina interna sistematica 48
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients 47
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma 47
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients 46
Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. 46
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy 45
60PV related lesions in HIV positive subjects on HAART: Study of viral markers of cervical neoplasia progression 45
Early diagnosis of HIV infection in infants 45
Incidence and risk factors of neurosurgical site infections: results of a prospective multicenter cohort study on 6359 surgeries 45
Uberti Foppa C, Gaiera G; Novati R Cap. 94 - Infezioni sistemiche in Rugarli C Medicina interna sistematica. Con CD-ROM 45
Saliva molecular testing for SARS-CoV-2: Simplifying the diagnosis without losing accuracy 45
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 44
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit 44
Immunological status in heroin addicts: effects of methadone maintenance treatment 44
Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission 44
Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated with Resolution or Chronicity 44
Uberti Foppa C, Gaiera G, Nunzi E, Spagnuolo V Capitolo 101 Infezioni sistemiche in: Rugarli Medicina interna sistematica 44
European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: Report from Italy 43
Child desire in women and men living with HIV attending HIV outpatient clinics: Evidence from a European multicentre study 43
Impact of HAART on liver histology of HIV/HCV coinfected patients 42
Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection 42
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA 42
Role of PMN's candidicidal activity in the pathogenesis of AIDS-related systemic candidiases 40
Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study 40
Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression 40
Reduced raltegravir clearance in HIV-infected liver transplant recipients: An unexpected interaction with immunosuppressive therapy? 40
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 40
Uberti Foppa C - Capitolo 18 - Influenza in Rugarli. Medicina interna sistematica 40
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 40
A prospective italian study on baseline NS3 and NS5A resistance to direct-acting antivirals in a real-world setting of HIV-1/HCV coinfected patients and association with treatment outcome 39
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 38
Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection 38
Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases 38
Uberti Foppa C Capitolo 18 - Influenza in Medicina interna sistematica. Con CD-ROM 38
Clinical and immunological aspects of HIV infection in drug addicts 37
Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease 37
Experiences with immunomodulant agents in HIV infections 37
Clinical and epidemiological aspects of the first 50 cases of AIDS in Milan 37
Compartmentalization of resistance-associated substitutions in hiv/hcv-infected patients: Possible correlation with infecting hcv genotype 37
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 36
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. 36
Risk of HIV-related diseases in heterosexuals importing infection from Zaire 35
LIVER STEATOSIS IN HIV/HCV COINFECTED AND HCV-MONOINFECTED PATIENTS: AN HISTOLOGICAL COMPARISON 35
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy 35
HIGH FREQUENCY OF TORQUE TENO VIRUS (TTV) INFECTION IN HIV-EXPOSED SERONEGATIVE INDIVIDUALS (ESN) AND THEIR HIV-POSITIVE SEXUAL PARTNERS 35
Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions 35
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 35
Clinical Outcomes in Persons Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment 35
Rugarli. Medicina interna sistematica 35
LIVER HISTOLOGY IN HIV/HCV COINFECTED PATIENTS WITH PERSISTENTLY NORMAL SERUM AMINOTRANSFERASES 34
Mutations in the natural strains of NS3 protease domain that confer resistance to anti-HCV protease inhibitors in HIV/HCV coinfected patients 34
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients 34
Patients' satisfaction with sexual and reproductive health services delivered in HIV clinics across European regions 34
Treatment of invasive fungal infetions in immunocompromised patients with fluconazole 33
Risk of human immunodeficiency virus infection in multiple transfused patients 33
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 33
Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection 33
Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy 33
OPPORTUNISTIC INFECTIONS 33
Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment 32
Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels 32
Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome 32
Febbre di origine sconosciuta 32
Infezioni sistemiche 32
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin 32
Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitors 32
Recombinant interferon-alpha therapy and meno-metrorrhagia 32
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 32
Totale 4.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 3 14 17 7 0 1 0
2021/2022117 0 0 0 53 4 9 9 12 10 4 4 12
2022/20231.070 434 257 65 4 13 110 52 70 45 12 7 1
2023/2024416 26 18 34 33 45 109 10 45 2 8 26 60
2024/20252.666 324 52 36 100 101 228 467 194 399 407 154 204
2025/20263.151 630 591 523 1.146 261 0 0 0 0 0 0 0
Totale 7.614